Crispr Therapeutics shares owned by Warren Averett Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Warren Averett Asset Management
from 13F filings
Historical chart of Warren Averett Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Warren Averett Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by Warren Averett Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $270k | 4.3k | 62.60 |
2023-06-30 | $256k | 4.6k | 56.14 |
More positions owned by Warren Averett Asset Management
View all positions for Warren Averett Asset Management